Second generation CB1 receptor blockers and other inhibitors of peripheral endocannabinoid overactivity and the rationale of their use against metabolic disorders-Reference-Cited by-同舟云学术

Second generation CB1 receptor blockers and other inhibitors of peripheral endocannabinoid overactivity and the rationale of their use against metabolic disorders

Published:2012-07-11 Issue:9 Volume:21 Page:1309-1322
ISSN:1354-3784
Container-title:Expert Opinion on Investigational Drugs
language:en
Short-container-title:Expert Opinion on Investigational Drugs

Author:

Silvestri Cristoforo¹,Di Marzo Vincenzo¹

Affiliation:

1. Institute of Biomolecular Chemistry – CNR, Endocannabinoid Research Group, Via Campi Flegrei 34, 80078, Pozzuoli (NA), Italy ; ;

Publisher

Informa UK Limited

Subject

Pharmacology (medical),Pharmacology,General Medicine

Link

https://www.tandfonline.com/doi/pdf/10.1517/13543784.2012.704019

Reference115 articles.

1. Clinical guidelines on the identification, evaluation, and treatment of overweight and obesity in adults: executive summary. Expert Panel on the Identification, Evaluation, and Treatment of Overweight in Adults

2. Prevalence and Trends in Obesity Among US Adults, 1999-2008

3. The medical complications of obesity

4. Discovery of endocannabinoids and some random thoughts on their possible roles in neuroprotection and aggression

5. Cannabinoid pharmacology: the first 66 years

Cited by 70 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Co-administration of Rimonabant prevents glucose intolerance in Sprague-Dawley rats treated chronically with Lopinavir/ritonavir and Zidovudine: an experimental study design;Pan African Medical Journal;2023

2. Cannabis and the GI tract;Handbook of Gastrointestinal Motility and Disorders of Gut-Brain Interactions;2023

3. Hemp seed significantly modulates the endocannabinoidome and produces beneficial metabolic effects with improved intestinal barrier function and decreased inflammation in mice under a high-fat, high-sucrose diet as compared with linseed;Frontiers in Immunology;2022-09-26

4. Long-term decreased cannabinoid type-1 receptor activity restores specific neurological phenotypes in the Ts65Dn mouse model of Down syndrome;2021-11-22

5. The Peripheral Cannabinoid Receptor Type 1 (CB1) as a Molecular Target for Modulating Body Weight in Man;Molecules;2021-10-13